<ul><li>Bernstein expresses caution over PB Fintech's plans to venture into healthcare with a $100 Mn investment.</li><li>Analysts believe this move would deviate from PB Fintech's asset-light model, potentially impacting its stock performance.</li><li>Despite concerns, Bernstein maintains an 'outperform' rating and sees potential for strengthening PB Fintech's position in the Indian health insurance market.</li><li>PB Fintech reported a net profit of INR 59.98 Cr in Q1 FY25 due to robust growth.</li></ul>

Bernstein Cautions On PB Fintech’s Healthcare Foray, Caps Downside At $100 Mn

Discover more